Thus, we could speculate that the effects of the IL-6 system on frailty, especially sarcopenia, may involve their contribution to lean body mass decrease, bone mineral density decrease, anemia, thrombocytosis, cholesterol and albumin decrease, insulin resistance, and cognitive impairment. The gene discussed is ALB; the disease is thrombocytosis disease.